Form 4: Bristol Myers Squibb CEO Transfers Over 62,000 Shares to Spousal Trust

Bristol Myers Squibb CEO Christopher S. Boerner has transferred 62,719 shares of common stock to a Spousal Lifetime Access Trust as part of a personal estate planning transaction.

Summary

• Christopher S. Boerner, Chief Executive Officer and Director of Bristol Myers Squibb Co (BMY), transferred 62,719 shares of common stock.
• The transaction occurred on June 13, 2025, and was coded as a 'G' transaction, indicating a gift.
• The shares were transferred at a price of $0, consistent with a gift or trust transfer.
• The transfer was made to a Spousal Lifetime Access Trust (SLAT) for estate planning purposes.
• Following this transaction, 125,439 shares are beneficially owned indirectly through the Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine personal estate planning transaction by an insider, with no direct positive or negative implications for the company's operational or financial performance.

Positives

• The transaction represents a personal estate planning move by the CEO, potentially optimizing his personal financial structure.

Negatives

• The transaction does not directly impact the company's operational performance or financial health.

Risks

• No specific risks to the company's operations or financial standing are indicated by this personal share transfer.

Future Outlook

This SEC Form 4 filing pertains to an insider's personal stock transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details a personal stock transaction by an executive and does not provide information relevant to broader industry trends or competitive dynamics within the pharmaceutical sector.

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a personal transaction by an executive and does not affect the company's operations or outstanding share count.
• Employees, Customers, Suppliers, Creditors: No direct impact.

Key Dates

Keywords

Bristol Myers Squibb, BMY, Christopher S. Boerner, SEC Form 4, Insider Transaction, Stock Transfer, Spousal Lifetime Access Trust, SLAT, Estate Planning, CEO